Interleukin-4 as a neuromodulatory cytokine: Roles and signaling in the nervous system

Annals of the New York Academy of Sciences

Volumn 1153, Issue , 2009, Pages 65-75

  Sholl Franco, Alfred ^a,b   Da Silva, Ana Gabriela Ledo Santos ^a   Adão Novaes, Juliana ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Programa de Neurobiologia   (Brazil)

Author keywords

Cell signaling; Development; Interleukin 4; Nervous system; Neuroimmunomodulation; Neuroinflammation

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AUTONOMIC NERVOUS SYSTEM; COMPLEX REGIONAL PAIN SYNDROME; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROIMMUNOLOGY; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PAIN; PARKINSON DISEASE; PROTEIN CEREBROSPINAL FLUID LEVEL; SIGNAL TRANSDUCTION;

EID: 60349106639     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03962.x     Document Type: Conference Paper

References (101)

1. Mosmann, T.R., H. Cherwinski, et al. 1986. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 : 2348 2357.
2. Szelényi, J. 2001. Cytokines and the central nervous system. Brain Res. Bull. 54 : 329 338.
3. Paul, W.E. 1997. Interleukin 4: signaling mechanisms and control of T cell differentiation. Ciba Found Symp. 204 : 208 216.
4. Laporte, S.L., C.M. Forsyth, et al. 2005. De novo design of an IL-4 antagonist and its structure at 1.9 A. Proc. Natl. Acad. Sci. USA 102 : 1889 1894.
5. Müeller, T.D., J. Zhang, et al. 2002. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Bioch. Biophys. Acta. 1592 : 237 250.
6. Nelms, K., A.D. Keegan, et al. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 : 701 738.
7. Murata, T., N. Obiri, et al. 1998. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors. Int. J. Mol. Med. 1 : 551 557.
8. Wells, J.A. & A.M. De Vos. 1996. Hematopoietic receptor complexes. Annu. Rev. Biochem. 65 : 609 634.
9. Hinton, H.J. & M.J. Welham. 1999. Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hemopoietic cells. J. Immunol. 162 : 7002 7009.
10. Galizzi, J.P., C.E. Zuber, et al. 1990. Molecular cloning of a cDNA encoding the human interleukin-4 receptor. Int. Immunol. 2 : 669 675.
11. Russell, S.M., A.D. Keegab, et al. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262 : 1880 1883.
12. Kelly-Welch, A.E., E.M. Hanson, et al. 2003. Interleukin-4 and interleukin-13 signaling connections maps. Science 300 : 1527 1528.
13. Finney, M., G.R. Guy, et al. 1990. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur. J. Immunol. 20 : 151 156.
14. Ikizawa, K., K. Kajiwara, et al. 1996. Evidence for a role of phosphatidylinositol 3-kinase in IL-4-induced germline C epsilon transcription. Cell Immunol. 170 : 134 140.
15. Silva, A.G.L.S., P. Campello-Costa, et al. 2008. Interleukin-4 blocks proliferation of retinal progenitor cells and increases rod photoreceptor differentiation through distinct signaling pathways. J. Neuroimmunol. 196 : 82 93.
16. Sholl-Franco, A., P.M.B. Marques, et al. 2001. Antagonistic and synergistic effects of combined treatment with interleukin-2 and interleukin-4 on mixed retinal cell cultures. J. Neuroimmunol. 113 : 40 48.
17. Sholl-Franco, A., C.M. Figueiredo, et al. 2002. Interleukin-4 increases the GABAergic phenotype in rat retinal cell cultures: involvement of muscarinic receptors and protein kinase C. J. Neuroimmunol. 133 : 20 29.
18. Butovsky, O., Y. Ziv, et al. 2006. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 3 : 149 160.
19. Eriksson, P.S., E. Perfilieva, et al. 1998. Neurogenesis in the adult human hippocampus. Nat. Med. 4 : 1313 1317.
20. Butovsky, O., A.E. Talpalar, et al. 2005. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective. Nat. Med. 29 : 381 393.
21. Brodie, C., N. Goldreich, et al. 1998. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J. Immunol. 81 : 20 30.
22. Scully, I.L. & U. Otten. 1995. NGF: Not just neurons. Cell Biol. Inst. 19 : 459 469.
23. Varon, S. & J.M. Connor. 1994. Nerve growth factor in CNS repair. J. Neurotrauma 11 : 473 486.
24. Araujo, D.M. & C.W. Cotman. 1993. Trophic effects of interleukin-4,-7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600 : 49 55.
25. Eddleston, M. & L. Mucke. 1993. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54 : 15 36.
26. Giulian, D. & L.B. Lachman. 1985. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228 : 497 499.
27. Suzumura, A., M. Sawada, et al. 1994. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatability complex antigen expression. J. Neuroimmunol. 53 : 209 218.
28. Simmons, M. & S. Murphy. 1993. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5 : 825 831.
29. Chao, C.C., T.W. Molitor, et al. 1993. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151 : 1473 1481.
30. Sholl-Franco, A., K.G.A. Figueiredo, et al. 2001. Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture. NeuroReport 12 : 109 112.
31. Koeberle P.D., J. Gauldie, et al. 2004. Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience 125 : 903 920.
32. van Soest, S., A. Westerveld, et al. 1999. Retinitis pigmentosa: defined from a molecular point of view. Surv. Ophthalmol. 43 : 321 334.
33. Adão-Novaes, J. 2007. Regulação in vitro da morte celular de fotorreceptores induzida por ácido ocadáico e tapsigargina: efeito neuroprotetor de citocinas. Ms thesis, Universidade Federal do Rio de Janeiro, Rio de Janeiro.
34. Nolan, Y., O.F. Mahert, et al. 2005. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J. Biol. Chem. 280 : 9354 9362.
35. Maher, F.O., Y. Nolan, et al. 2005. Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol. Aging 26 : 717 728.
36. Pousset, F., S. Cremona, et al. 1999. Interleukin-4 and interleukin-10 regulate IL1-β induced mouse primary astrocyte activation: a comparative study. Glia 26 : 12 21.
37. Sawada, M., Y. Itoh, et al. 1993. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett. 160 : 131 134.
38. Barton, K., M.T. McLauchlan, et al. 1995. The kinetics of cytokine mRNA expression in the retina during experimental autoimmune uveoretinitis. Cell Immunol. 164 : 133 140.
39. Zheng, M. & S.S. Atherton. 2005. Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis Invest. Ophthalmol. Vis. Sci. 46 : 1356 1363.
40. Safieh-Garabedian B., J.J. Haddad, et al. 2004. Cytokines in the central nervous system: targets for therapeutic intervention. Curr. Drug Targets CNS Neurol. Disord. 3 : 271 280.
41. Weisman, D., E. Hakimian, et al. 2006. Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitamins Hormones 74 : 505 530.
42. Aloisi, F. 2001. Immune function of microglia. Glia 36 : 165 179.
43. Kim, W.G., R.P. Mohney, et al. 2000. Regional difference in susceptibility to liplpolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20 : 6309 6316.
44. Skaper, S.D. 2007. The brain as a target for inflammatory processes and neuroprotective strategies. Ann. N. Y. Acad. Sci. 1122 : 23 34.
45. Benveniste, E.N., V.T. Nguyen, et al. 2001. Immunological aspecsts of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39 : 381 391.
46. Park, K.W., D.Y. Lee, et al. 2005. Neuroprotective role of microglia expressing interleusin-4. J. Neurosci. Res. 21 : 397 402.
47. Niinobu, T., K. Fukuo, et al. 2000. Negative feedback regulation of activated macrophages via Fas-mediated apoptosis. Am. J. Physiol. Cell Physiol. 279 : 504 509.
48. Yadav, M.C., E.M. Burudi, et al. 2007. IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 55 : 1385 1396.
49. Furlan, R., A. Bergami, et al. 2000. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulanting T cells producing interferon-gamma and interleukin-4. J. Neuroimmunol. 111 : 86 92.
50. Cannella, B. & C.S. Raine. 2004. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 55 : 46 57.
51. Butovsky, O., G. Landa, et al. 2006. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 116 : 905 915.
52. Zubenko, G.S. 1997. Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev. Psychiatry 5 : 177 213.
53. Walker, D.G., S.U. Kim, et al. 1995. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40 : 478 493.
54. Araujo, D.M. & C.W. Cotman. 1992. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569 : 141 151.
55. Klegeris, A. & P.L. McGeer. 1997. β-amyloid protein enhances macrophage production of oxygen free radical and glutamate. J. Neurosci. Res. 49 : 229 235.
56. Szczepanik, A.M., S. Funes, et al. 2001. IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia a human monocyte cell line. J. Neuroimmunol. 113 : 49 62.
57. Chao, C.C., S. Hu, et al. 1994. Transforming growth factor-β protects human neuron against β-amyloid-induced injury. Mol. Chem. Neuropathol. 23 : 159 178.
58. Iribarren, P., K. Chen, et al. 2005. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid β1-42, in TNFα-activated microglia. J. Immunol. 175 : 6100 6106.
59. Weintraub D., C.L. Comella, et al. 2008. Parkinson's disease - Part 1: pathophysiology, symptoms, burden, diagnosis, and assessment. Am. J. Manag. Care 14 : S40 S48.
60. Chen, L.W., K.L. Yung, et al. 2005. Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease. Curr. Drug Targets 6 : 821 833.
61. Nagatsu, T., M. Mogi, et al. 2000. Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural Transm. Suppl. 60 : 277 290.
62. Nagatsu, T., M. Mogi, et al. 2000. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 58 : 143 151.
63. Alexander, G.M., M.J. Perreault, et al. 2007. Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome. Brain Behav. Immunity 21 : 668 676.
64. Stoeck, K., B. Bodemer, et al. 2005. Interleukin-4 and interleukin-10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeld-Jakob disease. Arch. Neurol. 62 : 1591 1594.
65. Navikas, V. & H. Link. 1996. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45 : 322 333.
66. Söderström, M., J. Hillert, et al. 1995. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease. Mult. Scler. 1 : 173 180.
67. Link, J., M. Söderström, et al. 1994. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann. Neurol. 36 : 379 386.
68. Bartosik-Psujek, H. & Z. Stelmasik. 2005. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients. J. Neural Transm. 112 : 797 803.
69. Widhe, M., B.H. Skogman, et al. 2005. Up-regulation of Borrelia-specific IL-4- and IFN-γ-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int. Immunol. 17 : 1283 1291.
70. Nagatsu, T. & M. Sawada. 2005. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 11 : 999 1016.
71. Weber, F. 2002. Effects of autoreactive T cells and cytokines in the pathogenesis of multiple sclerosis. Int. MS J. 9 : 29 35.
72. Holmøy, T. 2007. Immunopathogenesis of multiple sclerosis: concepts and controversies. Acta Neurol. Scand. 115 : 39 45.
73. Lu, C.Z., M.A. Jensen, et al. 1993. Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 46 : 123 128.
74. Cannella, B. & C.S. Raine. 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37 : 424 435.
75. Hulshof, S., L. Montagne, et al. 2002. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38 : 24 35.
76. Kuchroo, V.K., M.P. Das, et al. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 : 707 718.
77. Racke, M.K., A. Bonomo, et al. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180 : 1961 1966.
78. Furlan, R., P.L. Poliani, et al. 1998. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Human Gene Ther. 9 : 2605 2617.
79. Furlan, R., P.L. Poliani, et al. 2001. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther. 8 : 13 19.
80. Croxford, J.L., K. Triantaphyllopoulos, et al. 1998. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. J. Immunol. 160 : 5181 5187.
81. Martino, G., P.L. Poliani, et al. 2000. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. J. Neuroimmunol. 107 : 184 190.
82. Cunha, F.Q., S. Poole, et al. 1999. Cytokinemediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 126 : 45 50.
83. Vale, M.L., J.B. Marques, et al. 2003. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan induced knee joint incapacitation in rats. J. Pharmacol. Exp. Ther. 304 : 102 108.
84. Hao, S., M. Mata, et al. 2006. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol. Pain 2 : 6.
85. Mijatovic, T., V. Kruys, et al. 1997. Interleukin-4 and -13 inhibit tumor necrosis factor-alpha mRNA translational activation in lipopolysaccharide- induced mouse macrophages. J. Biol. Chem. 272 : 14394 14398.
86. Te Velde, A.A., R.J. Huijbens, et al. 1990. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76 : 1392 1397.
87. Kraus, J., C. Borner, et al. 2001. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 276 : 43901 43908.
88. Kraus, J., C. Börner, et al. 2006. Interferon-γ down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells. J. Neuroimmunol. 181 : 13 18.
89. Gölz, G., L. Uhlmann, et al. 2006. The cytokine/neurotrophin axis in peripheral axon outgrowth. Eur. J. Neurosci. 24 : 2721 2730.
90. Deretzi, G., S.H. Pelidou, et al. 2000. High inflammation and mild demyelination in the peripheral nervous system induced by an intraneural injection of RR interleukin-4. Cytokine 12 : 808 810.
91. Deboy, C.A., J. Xin, et al. 2006. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4+ T cells. Exp. Neurol. 201 : 212 224.
92. Zhu, J., E. Mix, et al. 1996. Dynamics of mRNA expression of interferon-γ, interleukin 4 and transforming growth factor β1 in sciatic nerves and lymphoid organs in experimental allergic neuritis. Eur. J. Neurol. 3 : 232 240.
93. Abbas, N., L.P. Zou, et al. 2000. Protective effect of rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-γ and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system. Autoimmunity 32 : 93 99.
94. Spina, D. & C.P. Page. 2002. Asthma - a need for a rethink? Trends Pharmacol. Sci. 23 : 311 315.
95. Collins, S.M. 1996. Similarities and dissimilarities between asthma and inflammatory bowel diseases. Alimentary Pharmacol. Ther. Suppl. 10 : 25 31.
96. Fryer, A.D., L.H. Stein, et al. 2006. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J. Clin. Invest. 116 : 228 236.
97. Nassenstein, C., D. Dawbarn, et al. 2006. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J. Allergy Clin. Immunol. 118 : 597 605.
98. Mawe, G.M., S.M. Collins, et al. 2004. Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut. Neurogastroenterol. Motil. 16 : 133 136.
99. Shea-Donohue, T., C. Sullivan, et al. 2001. The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J. Immunol. 167 : 2234 2239.
100. von Boyen, G.B.T., M. Steinkamp, et al. 2004. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 53 : 222 228.
101. Besser, M. & R. Wank. 1999. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol. 162 : 6303 6306.